# Open-Label Treatment Extension Study

> **NCT02896296** · PHASE3 · COMPLETED · sponsor: **Indivior Inc.** · enrollment: 208 (actual)

## Conditions studied

- Opioid Use Disorder
- Opioid-related Disorders

## Interventions

- **DRUG:** RBP-6000

## Key facts

- **NCT ID:** NCT02896296
- **Lead sponsor:** Indivior Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-08-17
- **Primary completion:** 2017-08-23
- **Final completion:** 2017-08-23
- **Target enrollment:** 208 (ACTUAL)
- **Last updated:** 2018-11-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02896296

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02896296, "Open-Label Treatment Extension Study". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02896296. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*